title: Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
authors: Hospital Albert Einstein Hospital, Sao Paulo, Brazil.
authors: Antonio Eduardo P
authors: AE
authors: Pesaro
authors: Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
authors: Christopher B
authors: CB
authors: Granger
authors: Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Federal University of Sao Paulo, Paulista School of Medicine, Sao Paulo, Brazil. Electronic address: renato.lopes@duke.edu.
authors: Renato D
authors: RD
authors: Lopes
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D001938:Brazil / Q000453:epidemiology; D002784:Cholesterol / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D000069438:Ezetimibe / Q000008:administration & dosage*; D000069499:Ezetimibe, Simvastatin Drug Combination / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D000069499:Ezetimibe, Simvastatin Drug Combination; D002784:Cholesterol; D000069438:Ezetimibe